BioSpace News Archive

Business

Recro Pharma Announces Key Executive Promotions to the Financial Team

Michael Celano has been promoted to COO, and Ryan D. Lake has been promoted to CFO.

January 3, 2018
·
6 min read
Drug Development

Innovation Pharmaceuticals Brilacidin Meets Key Secondary Endpoint in Mid-Stage Trial

Previously released results from the study showed the use of Brilacidin-OM met its primary endpoint with a clearly reduced incidence of severe OM compared to placebo.

January 3, 2018
·
9 min read
Deals

ASLAN Pharmaceuticals Pays $129M to Acquire Full Global Commercial Rights for Varlitinib From Array BioPharma

The new licensing agreement replaces the prior licensing agreement signed in 2011 to develop and sublicense varlitinib, which did not grant commercial rights to ASLAN.

January 3, 2018
·
4 min read
Biotech Bay

Varian to Discuss New Reporting Standards

Varian today announced that it will webcast a conference call to discuss its transition to the new Accounting Standard Codification 606.

January 3, 2018
·
1 min read
Genetown

Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) January 3, 2018

Sage Therapeutics announced that, on January 2, 2018, the Compensation Committee of Sage’s Board of Directors granted non-qualified stock options to purchase an aggregate of 144,800 shares of its common stock to fifteen new employees under Sage’s 2016 Inducement Equity Plan.

January 3, 2018
·
2 min read
Pharm Country

Helius Medical Technologies Announces Closing of Second Tranche of Private Placement

The net proceeds of the Private Placement will be used by the Company to finance the Company’s near-term operations.

January 3, 2018
·
6 min read
Biotech Bay

Accuray Elects Net Share Settlement for 3.50% Series A Convertible Senior Notes Due 2018

The Specified Cash Amount for each $1,000 principal amount of Series A Notes converted will be $1,000.

January 3, 2018
·
4 min read
FDA

Mevion Snags FDA 510(k) Clearance for HYPERSCAN Pencil Beam Scanning

HYPERSCAN PBS introduces novel energy layer switching and automated collimation systems.

January 3, 2018
·
5 min read
CanniMed Releases New Letter to Shareholders

Cannimed releases a new letter to shareholders highlighting the benefits of acquiring all of the issued and outstanding shares of Newstrike Resources Ltd. and warning of the risks posed by Aurora Cannabis Inc.’s hostile bid to acquire all of the common shares of the Company.

January 3, 2018
·
22 min read
Genetown

Siamab Therapeutics to Present New Data on its ST1 Antibody Therapeutic Program Targeting Tumor-Associated STn and MDSCs at Biotech Showcase 2018

Siamab Therapeutics announced that Jeff Behrens, president and chief executive officer, will present at the 10th annual Biotech Showcase™ conference in San Francisco on Tuesday, January 9, 2018.

January 3, 2018
·
3 min read